Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
B-cell receptor-associated protein 29 (BCAP29) is a membrane-associated protein encoded on human chromosome 7. It acts as a chaperone, facilitating the correct ER-to-Golgi trafficking of proteins such as P-glycoprotein, and retaining membrane-bound IgD in the ER. BCAP29 is involved in cellular processes such as osteoblast differentiation, protein processing, and in certain contexts, apoptosis. Although a fusion transcript DUS4L-BCAP29 has been observed to promote cellular proliferation in both cancer/non-cancer cells, BCAP29 itself is not classically regarded as a cancer driver, therapeutic target, or major biomarker. Alternative isoforms such as Bap29varP modulate trafficking of specific proteins and play roles in multidrug resistance. The protein is widely expressed and is mainly localized to cellular membranes and the endoplasmic reticulum. If further granularity for structure, tissue distribution, or pathway context is needed, datasets from AllianceGenome, GeneCards, and Harmonizome provide detailed associations for BCAP29 gene/protein across biological compartments and interacting partners.
Not applicable; no approved drugs targeting BCAP29 directly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on B-cell receptor-associated protein 29 (BCAP29).